Product Code: VMR112110818
The global demand for High-Throughput Screening Market is presumed to reach the market size of nearly USD 96.38 BN by 2030 from USD 20.29 BN in 2022 with a CAGR of 21.5% under the study period 2023 - 2030.
High-throughput screening (HTS) is a method used in drug discovery and molecular biology to quickly and efficiently test a large number of chemical compounds or biological molecules for their ability to interact with a target of interest. The goal of HTS is to identify potential drug candidates or biological molecules that can modulate the activity of a specific target, such as a protein or enzyme. HTS involves the use of automated systems, robotics, and advanced data analysis tools to screen thousands or even millions of compounds or molecules in a short period of time. Typically, a large library of compounds or molecules is screened against a target of interest, and the compounds that show promising activity are further evaluated in more detailed studies.
Market Dynamics:
With the growing prevalence of various diseases such as cancer, Alzheimer's disease, and autoimmune disorders, there is an increasing demand for novel drug discovery. HTS enables researchers to screen a large number of compounds rapidly, which helps in identifying potential candidates for drug development. The development of advanced automated screening systems, robotics, and data analysis tools has led to improvements in the efficiency and accuracy of HTS. This has enabled researchers to screen a larger number of compounds more quickly and efficiently, reducing the time and cost of drug discovery. The increasing investments by companies operational in the pharmaceutical and biotechnology field, as well as academic research institutions, have contributed to the growth of the HTS market. The government initiatives for funding research and development activities in the pharmaceutical and biotechnology industries have further contributed to the growth of the HTS market. With the rise of personalized medicine, there is a growing need for targeted drug therapies. HTS plays a crucial role in the development of personalized medicine by enabling the screening of a large number of compounds and identifying the ones that are most effective for a specific patient. The growth in chronic diseases, such as cancer and diabetes, has led to a growing need for new drug therapies. HTS can accelerate the discovery of new drug candidates, making it an important tool in the development of new treatments for chronic diseases.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of high-throughput screening. The growth and trends of high-throughput screening industry provide a holistic approach to this study.
Market Segmentation:
This section of the high-throughput screening market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product & Service
- Consumables (Reagents & Assay Kits, Laboratory Equipment)
- Instruments (Liquid Handling Systems, Detection Systems, Other Instruments)
- Services
- Software
By Technology
- Cell-Based Assays (2D Cell Culture, 3D Cell Culture, Reporter-Based Assays, Perfusion Cell Culture)
- Lab-On-A-Chip Technology (LOC)
- Label-Free Technology
By Application
- Drug Discovery
- Biochemical Screening
- Life Sciences Research
- Other Applications
By End User
- Pharmaceutical % Biotechnology Companies
- Academic & Research Institutes
- Contract Research Organizations
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the High-Throughput Screening market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
- Global High-Throughput Screening Market Share by Region (Representative Graph)
- Global High-Throughput Screening Market Share
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the high-throughput screening market include Thermo Fisher Scientific Inc., Agilent Technologies Inc., Danaher Corporation, PerkinElmer Inc., Tecan Group Ltd., AXXAM S.p.A., Merck KGaA, Bio-Ras Laboratories Inc., Promega Corporation, Corning Incorporated and Eurofins Scientific. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
TABLE OF CONTENTS
1 . PREFACE
- 1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3 . HIGH-THROUGHPUT SCREENING - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product & Service
- 3.7.2 Market Attractiveness Analysis By Technology
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By End User
- 3.7.5 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend
5 . GLOBAL HIGH-THROUGHPUT SCREENING MARKET ANALYSIS BY PRODUCT & SERVICE
- 5.1 Overview by Product & Service
- 5.2 Historical and Forecast Data
- 5.3 Analysis by Product & Service
- 5.4 Consumables (Reagents & Assay Kits, Laboratory Equipment) Historic and Forecast Sales by Regions
- 5.5 Instruments (Liquid Handling Systems, Detection Systems, Other Instruments) Historic and Forecast Sales by Regions
- 5.6 Services Historic and Forecast Sales by Regions
- 5.7 Software Historic and Forecast Sales by Regions
6 . GLOBAL HIGH-THROUGHPUT SCREENING MARKET ANALYSIS BY TECHNOLOGY
- 6.1 Overview by Technology
- 6.2 Historical and Forecast Data
- 6.3 Analysis by Technology
- 6.4 Cell-based Assays (2D Cell Culture, 3D Cell Culture, Reporter-based Assays, Perfusion Cell Culture) Historic and Forecast Sales by Regions
- 6.5 Lab-on-a-Chip Technology (LOC) Historic and Forecast Sales by Regions
- 6.6 Label-free Technology Historic and Forecast Sales by Regions
7 . GLOBAL HIGH-THROUGHPUT SCREENING MARKET ANALYSIS BY APPLICATION
- 7.1 Overview by Application
- 7.2 Historical and Forecast Data
- 7.3 Analysis by Application
- 7.4 Drug Discovery Historic and Forecast Sales by Regions
- 7.5 Biochemical Screening Historic and Forecast Sales by Regions
- 7.6 Life Sciences Research Historic and Forecast Sales by Regions
- 7.7 Other Applications Historic and Forecast Sales by Regions
8 . GLOBAL HIGH-THROUGHPUT SCREENING MARKET ANALYSIS BY END USER
- 8.1 Overview by End User
- 8.2 Historical and Forecast Data
- 8.3 Analysis by End User
- 8.4 Pharmaceutical % Biotechnology Companies Historic and Forecast Sales by Regions
- 8.5 Academic & Research Institutes Historic and Forecast Sales by Regions
- 8.6 Contract Research Organizations Historic and Forecast Sales by Regions
9 . GLOBAL HIGH-THROUGHPUT SCREENING MARKET ANALYSIS BY GEOGRAPHY
- 9.1. Regional Outlook
- 9.2. Introduction
- 9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Data Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
- 9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Data Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
- 9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Data Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. Rest Of Asia Pacific Sales Analysis
- 9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Data Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
- 9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Data Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis
10 . COMPETITIVE LANDSCAPE OF THE HIGH-THROUGHPUT SCREENING COMPANIES
- 10.1. High-Throughput Screening Market Competition
- 10.2. Partnership/Collaboration/Agreement
- 10.3. Merger And Acquisitions
- 10.4. New Product Launch
- 10.5. Other Developments
11 . COMPANY PROFILES OF HIGH-THROUGHPUT SCREENING INDUSTRY
- 11.1. Company Share Analysis
- 11.2. Market Concentration Rate
- 11.3. Thermo Fisher Scientific Inc.
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
- 11.4. Agilent Technologies Inc.
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
- 11.5. Danaher Corporation
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
- 11.6. PerkinElmer Inc.
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
- 11.7. Tecan Group Ltd.
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
- 11.8. AXXAM S.p.A.
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
- 11.9. Merck KGaA
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments
- 11.10. Bio-Ras Laboratories Inc.
- 11.10.1. Company Overview
- 11.10.2. Company Revenue
- 11.10.3. Products
- 11.10.4. Recent Developments
- 11.11. Promega Corporation
- 11.11.1. Company Overview
- 11.11.2. Company Revenue
- 11.11.3. Products
- 11.11.4. Recent Developments
- 11.12. Corning Incorporated
- 11.12.1. Company Overview
- 11.12.2. Company Revenue
- 11.12.3. Products
- 11.12.4. Recent Developments
- 11.13. Eurofins Scientific.
- 11.13.1. Company Overview
- 11.13.2. Company Revenue
- 11.13.3. Products
- 11.13.4. Recent Developments
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies